Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2025-12-25 @ 1:43 AM
NCT ID:
NCT04521894
Eligibility Criteria:
Inclusion Criteria:
* 1 age between 40 and 100 years old
* 2 PSA \>0.4 ng/mL for primary PCa with biopsy proven or RP diagnosis of prostate cancer
* 3 PSA \>0.2 ng/mL after RP, PSA ≥2 ng/mL above the nadir after EBRT) or persisting PSA after radical treatment with rising PSA values
* 4 complete clinical, pathological, imaging and biochemical information
Exclusion Criteria:
* 1 lack of histological examinationproven diagnosis of PCa
* 2 18F-PSMA PET/CT being performed after pharmacotherapy since PSMA-targeted imaging can be disturbed by previous therapie
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
40 Years
Maximum Age:
100 Years
Study:
NCT04521894
Study Brief:
Protocol Section:
NCT04521894